Open AccessLong term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema
Author(s) -
Nicoletta Bernardini,
Nevena Skroza,
Giovanni Rossi,
Alessandra Mambrin,
Ersilia Tolino,
Federica Marraffa,
Martina Caviglia,
Antonio Di Guardo,
Salvatore Volpe,
Ilaria Proietti,
Concetta Potenza
Publication year - 2022
Publication title -
dermatology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.183
H-Index - 10
eISSN - 2036-7406
pISSN - 2036-7392
DOI - 10.4081/dr.2022.9447
Subject(s) - medicine , psoriasis , dermatology , tolerability , adverse effect
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom